Transplacental treatment of fetal tachycardia: A systematic review and meta-analysis.
Garick D HillJoshua R KovachDavid E SaudekAnoop K SinghKarla WehrheimMichele A FrommeltPublished in: Prenatal diagnosis (2018)
Digoxin should not be first-line therapy for fetal tachycardia, particularly in the presence of hydrops fetalis. Flecainide should be the first-line therapy of choice in atrioventricular reentrant tachycardia. Further study may identify further sub-populations responding differently.